{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "14028 Children  YP with Acute Immune Thrombocytopenic Purpura 2.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "MANAGEMENT AND FOLLOW UP OF CHILDREN AND ADOLESCENTS WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA (ITP)"
                    },
                    {
                        "text": "Clinical Guideline Register No 14028 Status: Public"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 3,
            "data": {
                "num_rows": 20,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Developed in Response to:"
                    },
                    {
                        "text": "Best practice"
                    },
                    {
                        "text": "Contributes to CQC Outcome"
                    },
                    {
                        "text": "11, 12"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Consulted With"
                    },
                    {
                        "text": "Post/Committee/Group"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "Alison Cuthbertson / Miss Rao"
                    },
                    {
                        "text": "Divisional Director for Women's and Children's"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Melanie Chambers"
                    },
                    {
                        "text": "Lead Nurse Children and Young People"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Mel Hodge"
                    },
                    {
                        "text": "Senior Sister Phoenix Children's Unit"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Mary Stebbens"
                    },
                    {
                        "text": "Clinical Facilitator Paediatrics"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Agrawal"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Cyriac"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Hassan"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Joseph"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Lethaby"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Lim"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Muthumeenal"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Nambiar"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Ottayil"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Dr Thomas"
                    },
                    {
                        "text": "Associate Specialist Paediatrics"
                    },
                    {
                        "text": "25th June 2018"
                    },
                    {
                        "text": "Professionally Approved by:"
                    },
                    {
                        "text": "Dr Datta Clinical Director Children's Services"
                    },
                    {
                        "text": "28th June 2018"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Version Number"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Issuing Directorate"
                    },
                    {
                        "text": "Children and Young People"
                    },
                    {
                        "text": "Ratified by:"
                    },
                    {
                        "text": "Document Ratification Group Chairman's Action"
                    },
                    {
                        "text": "Ratified on:"
                    },
                    {
                        "text": "29th June 2018"
                    },
                    {
                        "text": "Executive Team Sign off Date"
                    },
                    {
                        "text": "July 2018"
                    },
                    {
                        "text": "Implementation Date"
                    },
                    {
                        "text": "10th July 2018"
                    },
                    {
                        "text": "Next Review Date"
                    },
                    {
                        "text": "May 2021"
                    },
                    {
                        "text": "Author/Contact for Information"
                    },
                    {
                        "text": "Dr Joseph, Consultant Paediatrician Oncology/Palliative Lead"
                    },
                    {
                        "text": "Policy to be followed by ( target staff )"
                    },
                    {
                        "text": "Nurses, Junior Doctors, Paediatricians, Community Paediatric Specialist Nurses"
                    },
                    {
                        "text": "Distribution Method"
                    },
                    {
                        "text": "Intranet and Website"
                    },
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Paediatric Assessment Unit Operational Policy 04064 Safeguarding Children and Young People 09026 Children's Discharge Policy 05118 Chaperone Policy 04071 Standard Infection Prevention 04072 Hand Hygiene 09127 Interpreting and Translation Policy"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 5,
            "data": {
                "is_heading": 0,
                "text": "Document Review History"
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Version No"
                    },
                    {
                        "text": "Authored/Reviewed by"
                    },
                    {
                        "text": "Issue Date"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Dr Manas Datta"
                    },
                    {
                        "text": "30th October 2014"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Joseph Ranjith"
                    },
                    {
                        "text": "10th July 2018"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Index 1.0  Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality and Diversity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Definition"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Background"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Pathogenesis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Physical Examination"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Diagnosis and Types of ITP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Investigation and assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Differential Diagnosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Inpatient Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Adverse Reactions of Intravenous Immunoglobulin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "General Measures"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Adjuvant Treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Conservative Outpatient Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Prognosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Discharge and Follow-up"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Staff Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Communication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Appendices"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "text": "Appendix A \u2013 Doses and Method of Administration"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "Appendix B \u2013 Management Plan for Suspected Childhood ITP Appendix C \u2013 What is Childhood ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "Appendix D \u2013 ITP in Children"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "Appendix E \u2013 ITP in Teenagers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "Appendix F \u2013 Holiday Arrangements Summary"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "1.1. The purpose of this guideline is to ensure appropriate and up to date management of children and adolescents with immune thrombocytopenic purpura (ITP)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality and Diversity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "2.1. The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all persons concerned."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "3.1. This guideline has been created for the use of all staff caring for children and adolescents till they attain 16 years of age."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Definition"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "4.1. Acute Immune Thrombocytopenic (ITP) is an autoimmune disorder characterised by severe thrombocytopenia and mucocutaneous bleeding due to destruction of platelets by circulating antibody. (Platelet count < 100x109/L in the absence of any underlying cause)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "Patients fall broadly into two categories:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "1) Acute (80- 90%): self-limiting disease (sometimes preceded by a viral syndrome) with spontaneous resolution within 6 months (usually within 2 months)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "2) Chronic (10 -20%): does not remit within 6 months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 1,
                "text": "4.2. A child with typical acute ITP:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "text": "Is usually otherwise completely well with no history of any major illness, bone or joint pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "text": "Is most commonly between 2 and 5 years of age (ITP can occur at any age but in neonates and children over 10 years of age other diagnoses are more likely and should be actively excluded)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "text": "Presents with sudden onset of petechiae and bruising"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "text": "Has often had a recent viral illness or vaccination"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Has no family or personal history of thrombocytopenia or other bleeding disorders"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "Has no splenomegaly or lymphadenopathy on clinical examination"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "text": "Is not on medication that can cause thrombocytopenia (eg. Sodium valproate)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "Has a very low platelet count (usually <20x109/l, often in single figures)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "Has an otherwise completely normal blood count for age"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "If there are any atypical features the case should be discussed with the attending Paediatric Consultant"
            }
        },
        {
            "type": "image",
            "sequence_num": 57,
            "data": {
                "url": "14028 Children  YP with Acute Immune Thrombocytopenic Purpura 2.0.002.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Background"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "5.1. Childhood ITP affects 4-6 of 100.000 children per year. The peak age is between 1 and 4 years, although it can affect people from early in infancy to the elderly. A recent history of viral illness is described in about 50% of cases of childhood ITP. ITP is an acquired thrombocytopenia due to immune mediated shortened circulating platelet survival in the absence of any underlying disorders of haemostasis or coagulation. ITP is a diagnosis of exclusion when investigations do not suggest an alternative cause. Previously it used to be called Idiopathic Thrombocytopenic Purpura."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Pathogenesis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 1,
                "text": "6.1. Platelet autoantibodies (usually IgG) attach to the platelets and the immune complexes are removed from the circulation by the reticuloendothelial system, especially the spleen. The normal lifespan of a platelet is 7-10 days but in ITP this is usually reduced to few hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Physical examination"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "text": "7.1. Obtain verbal consent from patient/parent and provide age appropriate explanation. Follow the Chaperone Policy if patient is not accompanied by a parent/guardian prior to physical examination."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "text": "7.2. Findings on physical findings are normal, other than the findings of petechiae and purpura. The presence of abnormal findings such as hepatosplenomegaly, bone or joint pain, or significant lymphadenopathy suggests other diagnoses (Leukaemia). When the onset is insidious, especially in adolescent, consider chronic ITP or the possibility of a systemic illness, such as Systemic Lupus Erythematosus (SLE)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "7.3. Consider safeguarding issues, especially in younger children particularly if there is concerning history. Blood test will confirm ITP although abuse can happen in these children as well."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Diagnosis and Types of ITP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "8.1. The classic presentation of acute ITP is a previously healthy 1-4 yr old child who has sudden onset of generalized petechiae and purpura. Often there is bleeding from the gums and mucous membranes, particularly with profound thrombocytopenia (platelet count <10 \u00d7 10/L). There may be history of a preceding viral infection 1-4 week before the onset of thrombocytopenia.Life threatening bleeding is very uncommon. The incidence of intracranial haemorrhage is much less than 1%, and very rare in uncomplicated childhood ITP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "8.2. An easy to use classification system has been proposed in the UK to characterise the severity of bleeding in ITP on the basis of symptoms and signs, but not platelet count:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "text": "1) No symptoms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "text": "2) Mild symptoms: bruising and petechiae, occasional minor epistaxis, very little interference with daily living"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "3) Moderate: more severe skin and mucosal lesions, more troublesome epistaxis and menorrhagia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "text": "4) Severe: bleeding episodes\u2014menorrhagia, epistaxis, meleana\u2014requiring transfusion or hospitalization, symptoms interfering seriously with the quality of life"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "text": "8.3. About 20% of the children who present with acute ITP will have persistent thrombocytopenia for more than 12 months and are said to have Chronic ITP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Investigation and Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "text": "9.1. The diagnosis of ITP is one of exclusion and is based on the history, clinical examination, full blood count and inspection of the peripheral blood film. Further diagnostic studies are not generally indicated in the routine investigation of children with suspected ITP but may be appropriate when the diagnosis is in doubt or the presentation is atypical."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "text": "9.2. Full blood count"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "text": "This shows isolated thrombocytopenia and is otherwise normal unless significant bleeding, e.g. epistaxis, has caused anaemia. An abnormal white cell count or differential count should prompt further investigations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "9.3. Blood film examination"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "This should be entirely normal except for thrombocytopenia often with occasional large platelets. A few viral/reactive lymphocytes may be seen if there has been a recent viral illness. Any other red or white cell changes merit further investigation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "The blood film should be examined carefully by a haematologist."
            }
        },
        {
            "type": "image",
            "sequence_num": 81,
            "data": {
                "url": "14028 Children  YP with Acute Immune Thrombocytopenic Purpura 2.0.003.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Further investigations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "1) Coagulation screening is not required unless there is doubt about the diagnosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "2) Bone marrow examination is not required unless there is a doubt about the diagnosis or in atypical chronic cases"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "3) Additional investigations to screen for other auto-immune disorders, eg lupus"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "or antiphospholipid syndrome, may be appropriate in older children/teenagers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Differential Diagnosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "text": "Leukaemia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "Aplastic Anaemia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "Fanconi's anaemia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Von Willebrand's disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "Meningococcal septicaemia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "Henoch \u2013 SchonleinPurpura"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "Non-accidental injury"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "Disseminated intravascular coagulation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "HIV infection"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "Other autoimmune disorders"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "Platelet function disorders"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "Infections"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "Drug effects (i.e heparin, sulfonamides)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "Hypersplenism"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Inpatient Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 1,
                "prefix": 11.1,
                "text": "More that 80-90% of children with acute ITP do not have serious bleeding problems despite very low platelet counts and do not require treatment. The need for treatment should be guided by the clinical signs and not the platelet count."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "Classification of severity of bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 1,
                "text": "Mild: Skin petechiae, purpura and small bruises. Occasional short mucosal bleeds (nose, gastrointestinal tract, genitourinary tract)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 1,
                "text": "Moderate: More extensive ecchymoses, recurrent or prolonged (over 30 minutes) mucosal bleeds gum bleeding, haematuria etc."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 1,
                "text": "Severe/life threatening: Intracranial haemorrhage (ICH) or massive gastrointestinal bleed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "Advice and Consultation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "text": "Any child requiring active treatment should be discussed with the attending consultant paediatrician and/or the consultant haematologist before starting treatment. In the event of more severe bleeding, or life-threatening bleeding requiring emergency treatment, the case should also be discussed with a tertiary centre, usually St Mary's Hospital Paddington (on-call Consultant Haematologist), or Great Ormond Street Hospital for advice and consideration of urgent transfer for specialist assessment and/or treatment. The outcome should be documented in the patient record using the tertiary discussion form."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "The most dangerous complication of ITP is intracranial haemorrhage. This is very rare (about 0.5%) even with very low counts and independent of treatment but if there are clinical features to suggest possible ICH, eg persistent headache, an urgent CT scan of the head should be arranged. A neurological assessment, including examination, should be documented in medical records."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "text": "The attending Consultant Paediatrician must be involved in the decision to perform a CT scan and actions thereafter. The Paediatrician with special interest"
            }
        },
        {
            "type": "image",
            "sequence_num": 112,
            "data": {
                "url": "14028 Children  YP with Acute Immune Thrombocytopenic Purpura 2.0.004.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "text": "in Haematology and Consultant Haematologist should be informed."
            }
        },
        {
            "type": "image",
            "sequence_num": 114,
            "data": {
                "url": "14028 Children  YP with Acute Immune Thrombocytopenic Purpura 2.0.005.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "prefix": 11.4,
                "text": "Treatment of the Child Presenting with ITP (See Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "If prednisolone is used for treatment it must be checked whether the child has had chickenpox and if not, that the parents know to attend for zoster immunoglobulin (ZIG) immediately if their child has varicella contact. Prior to starting any child on prednisolone the case should be discussed with the Consultant Haematologist or attending consultant. A steroid card should be issued."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 1,
                "prefix": 11.5,
                "text": "Supportive Therapy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "Oral tranexamic acid 25 mg/kg tds as required if there is excessive mucosal bleeding but ensure that there is no overt clinical haematuria as clot retention may result. Tranexamic acid can also be used as a mouthwash (5% solution) to help with local gum bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "text": "Avoid intramuscular injections and platelet inhibiting drugs, eg aspirin or NSAIDs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "text": "Menorrhagia can be managed with oral contraceptive pills and anti- fibrinolytic agents. Life style issues should be taken into account in view of possible active treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "Written information on ITP should always be given to the parents (Appendix"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "2) \u2013 this can be downloaded from the UK Paediatric ITP Registry at www.uk- itp.org). Many parents benefit greatly from information available from ITP support groups such as The ITP Support Association (http://www.itpsupport.org.uk)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "text": "Open access to the Paediatric Admissions Unit should be arranged and parents should be given the phone number to ring in the event of bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "prefix": 11.6,
                "text": "What to Tell Parents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "text": "ITP is usually a self-limiting benign disorder"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "text": "It is a disorder that may sometimes last some weeks or months"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "text": "A minority of cases (10-20%) may become chronic with persistent thrombocytopenia for > 6 months but usually resolve fully in time. This is more common in children who are >10 years old and who have a presenting platelet count of >50x109/l"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "The child should be encouraged to have a normal lifestyle (ie, go to school) but avoid contact sports or activities with a high risk of trauma or injury to the head. The child should be brought back if they develop signs of wet mucosal, or any other significant, haemorrhage, or following a heavy blow to the head, particularly if the child is stunned or sickly, or has persistent or severe headache, vomiting or drowsiness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "text": "Treatment may result in a temporary improvement in the platelet count, sufficient to stop immediate bleeding, but will not resolve the ITP, which is self-limiting and remits in its own time"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "The use of aspirin or any non-steroidals such as ibuprofen must be avoided."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 1,
                "prefix": 11.7,
                "text": "Intravenous Immunoglobulin (IVIG) appears to induce a response by downregulating Fc-mediated phagocytosis of antibody-coated platelets. It usually causes a rapid rise in the platelet count in most patients within 48 hours. It can be given by either intravenous or subcutaneous route. There are many preparations available. We usually use Privigen, Vigam and Intratect. Other preparations are Flebogamma, Gammaplex etc. Check with the pharmacist before using these preparations. Flebogamma is contraindicated in children aged 0-2 years. Immunoglobulin can also be used subcutaneously but it must be done after discussion with the tertiary hospital"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 1,
                "text": "Dose:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "0.8 \u2013 1g/kg on day 1.Repeat doses may be considered by consultant if indicated. Alternate dose is 0.4g/kg daily for 2 \u2013 5 days."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 1,
                "text": "Method of administration:(See Appendix C)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Prednisolone orally. Corticosteroid therapy has been used for many years to treat acute and chronic ITP in adults and children. Doses of prednisone of 1-4 mg/kg/24 hr. appear to induce a more rapid rise in platelet count than in untreated patients with ITP. Whether bone marrow examination should be performed to rule out other causes of thrombocytopenia, especially acute lymphoblastic leukaemia, before institution of prednisone therapy in acute ITP is controversial.Corticosteroid therapy is usually continued for 2-3 wk. or until a rise in platelet count to >20 \u00d7 /L has been achieved, with a rapid taper to avoid the long-term side effects of corticosteroid therapy, especially growth failure, diabetes mellitus, and osteoporosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Intravenous anti-D immunoglobulin (anti-D)therapy.For Rh-positive patients, IV anti-D at a dose of 50-75 \u00b5g/kg causes a rise in platelet count to >20 \u00d7 10/L in 80- 90% of patients within 48-72 hr. When given to Rh-positive individuals (about 85% of the population are Rh positive), IV anti-D induces mild haemolytic anaemia. RBC- antibody complexes bind to macrophage Fc receptors and interfere with platelet destruction, thereby causing a rise in platelet count. IV anti-D is ineffective in Rh negative patients. Rare life-threatening episodes of intravascular haemolysis have occurred in children and adults following infusion of IV anti-D."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 1,
                "prefix": 11.1,
                "text": "Each of these medications may be used to treat exacerbations of ITP, which may occur several weeks after an initial course of therapy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Adverse reactions of Intravenous Immunoglobulin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "text": "Headache"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "text": "Dizziness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "text": "Vertigo"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "text": "Nausea/Vomiting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "text": "Fever/Fatigue"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "text": "Back pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "text": "Myalgia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "text": "Tachycardia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "text": "Itching/raised nettle rash/hives"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "Hypersensitivity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "text": "Anaphylaxis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "text": "Hypertension/Hypotension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "Injection site reaction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "text": "Tightness/Swelling around the neck"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "Wheezing/Chest pain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "Difficulty in breathing"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "Haemolytic anaemia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "Thromboembolism"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "General Measures"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "text": "13.1. Reassure patients and parents. Definitive urgent treatments to raise the platelet count are only given for severe uncontrolled mucous membrane bleeding or if ainvasive intervention or operation is planned; not based on low platelet counts. Even extensive purpura and bruising alone are not indication for treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "13.2. Hospital admission or enforced rest are not necessary but until resolution, it is advisable to restrict contact sport or activities with high risk of trauma. Avoid IM injections. Stop/do not prescribe NSAIDS and review medication currently taking."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "13.3. Provide families with contact name and 24 hour telephone number to access if required. Provide parents with details for ITP Support Association (http://www.itpsupport.ork.uk) as well as information leaflet."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Conservative Outpatient Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "text": "14.1. Most children will be managed on an outpatient basis if the following criteria are met:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "text": "14.2. The diagnosis is unequivocal with no clinical manifestations apart from the bruising and low platelets. There is no active bleeding and the child is otherwise well. Social circumstances allow confidence about the degree of parental supervision and relative safety of the home environment, particularly for young children."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "Please arrange follow up appointment with relevant consultant in the Phoenix Ward clinic within 2-4 weeks \u2013 consultant will decide regarding repeat blood tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "text": "14.3. If there is no significant increase in the platelet count within 3 months of initial presentation, discussion with a paediatric haematologist is advised."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Prognosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 0,
                "text": "15.1.  Childhood ITP is usually benign and self-limiting. 70-80% of children will have spontaneous resolution of the disease within 6 months. After remission children will continue their daily life activities as normal. About 20% of children will develop chronic ITP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Discharge and Follow-up"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "16.1. Children with acute ITP and mild clinical disease may be managed expectantly with supportive advice and a  h contact point. Irrespective of platelet count repeat the FBC and review the patient in hospital within 7-10 days of initial presentation. This is to check that there is no evidence of a serious marrow disorder such as aplastic anaemia/leukaemia emerging."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 0,
                "text": "16.2. Further checks are not necessary while a child still has purpura and remains clinically well."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 0,
                "text": "16.3. It is necessary if there is a change of symptoms or signs or any doubt as to the underlying diagnosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 0,
                "text": "Repeated unnecessary blood counts not only disrupt the child's schooling but cause distress and anxiety to the parents as well as the needle wary child."
            }
        },
        {
            "type": "image",
            "sequence_num": 173,
            "data": {
                "url": "14028 Children  YP with Acute Immune Thrombocytopenic Purpura 2.0.006.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "text": "16.4. Paediatric outpatient review to be arranged by the relevant consultant at 3 months and 6 months after diagnosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "text": "16.5. General Practitioner does not need to follow up child with ITP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "16.6. Parent Involvement and Documentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "text": "Ensure:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 0,
                "text": "Parents are informed of success rate and possible risks of treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 0,
                "text": "Parents are fully informed and involved in treatment decisions and any concerns are discussed and addressed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 180,
            "data": {
                "is_heading": 0,
                "text": "Parents are informed and consulted about decisions arising from Tertiary discussion"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 0,
                "text": "All discussions are documented in Healthcare records"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Staff Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 0,
                "text": "17.1. All medical and nursing staff must ensure that their knowledge, competencies and skills are up-to-date in order to complete their portfolio for appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 184,
            "data": {
                "is_heading": 0,
                "text": "17.2. During induction process junior medical staff will receive instruction on current policies and guidelines."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 185,
            "data": {
                "is_heading": 0,
                "text": "17.3. Case presentation and junior doctor teaching will discuss the management of ITP cases and learn from the outcomes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 186,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 0,
                "text": "18.1. All staff should follow Trust guidelines on infection prevention ensuring that they effectively \u2018decontaminate' their hands before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 188,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "text": "19.1. As an integral part of the knowledge, skills framework, staff is appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines available via the Trust's intranet site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 190,
            "data": {
                "is_heading": 0,
                "text": "19.2. Quarterly notifications are sent to line managers to disseminate to their staff the most currently approved guidelines available via the intranet and clinical guideline folders, located in each designated clinical area."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 191,
            "data": {
                "is_heading": 0,
                "text": "19.3. Where a child's notes have demonstrated that the appropriate action has not been taken a \u2018risk event form' is to be completed. This will address any further training needs for staff that required updating."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 192,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Communication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 193,
            "data": {
                "is_heading": 0,
                "text": "20.1. Approved guidelines are notified monthly in the Trust's Focus Magazine that is sent via email to all staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 194,
            "data": {
                "is_heading": 0,
                "text": "20.2. All ratified Clinical Guidelines are Clinical Policies are published on the intranet and on the Trust website."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 195,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 196,
            "data": {
                "is_heading": 0,
                "text": "Nelson Textbook of Pediatrics.Kleigman RM, Behrman RE, Jenson HB, Stanton BF. 19th ed. Philadelphia, Pa: Saunders; 2011"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 197,
            "data": {
                "is_heading": 0,
                "text": "ITP in Children: Pathophysiology and current treatment approaches. D'Orazio JA et al, JPediatrHematolOncol. 2013 Jan;35(1):1-13."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 198,
            "data": {
                "is_heading": 0,
                "text": "Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).Neunert et al, Blood. 2013 May 30;121(22):4457-62"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 199,
            "data": {
                "is_heading": 0,
                "text": "The Royal Children's Hospital Melbourne (2012), Clinical Practice Guidelines. Immune Thrombocytopenic Purpura."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 200,
            "data": {
                "is_heading": 0,
                "text": "Immune Thrombocytopenia.Provan D et al, Hematology. 2013 Jul;18(4):242-3"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 201,
            "data": {
                "is_heading": 0,
                "text": "Ashford and St. Peter's Hospitals (2006), Guidelines for management of Idiopathic Thrombocytopenic Purpura (ITP) in Children."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 202,
            "data": {
                "is_heading": 0,
                "text": "Changing trends in the UK management of childhood ITP. Grainger JD et al, Arch Dis Child. 2012 Jan;97(1):8-11"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 203,
            "data": {
                "is_heading": 0,
                "text": "Child and Adolescent Health Service Princess Margaret Hospital for Children(2012), Clinical Practice Guideline \u2013 Immune Thrombocytopenic Purpura (ITP)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 204,
            "data": {
                "is_heading": 0,
                "text": "Guy's and St Thomas' Hospital's Paediatric Formulary."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 205,
            "data": {
                "is_heading": 0,
                "text": "Luton and Dunstable Hospital \u2013 Immune Thrombocytopenic Purpura Paediatric Guidelines \u2013 March 2012"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 206,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 207,
            "data": {
                "is_heading": 1,
                "text": "Doses and Method of Administration IVIG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 208,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "0.8 \u2013 1g/kg on day  Dose may be repeated once within 3 days or 0.4g/kg daily for 2 \u2013 5 days."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 209,
            "data": {
                "is_heading": 1,
                "text": "Prednisolone"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 210,
            "data": {
                "is_heading": 0,
                "text": "1 -2 mg/kg/day orally for a maximum of 14-21 days and then rapidly taper;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 211,
            "data": {
                "is_heading": 0,
                "text": "or"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 212,
            "data": {
                "is_heading": 0,
                "text": "4mg/kg/day for 3 \u2013 4 days"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 213,
            "data": {
                "is_heading": 1,
                "text": "IV anti-D"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 214,
            "data": {
                "is_heading": 0,
                "text": "50-75 \u03bcg/kg IV"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 215,
            "data": {
                "is_heading": 1,
                "text": "Method of administration of IVIG:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 216,
            "data": {
                "is_heading": 0,
                "text": "For intravenous use"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 217,
            "data": {
                "is_heading": 0,
                "text": "A) Privigen 100mg/ml (10%) solution:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 218,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Privigen should be infused intravenously at an initial rate of 0.3ml/kg/hr for approximately  minutes. If well tolerated, the rate of administration may be increased gradually to a maximum of 4.8ml/kg/hr."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 219,
            "data": {
                "is_heading": 0,
                "text": "If dilution prior to infusion is desired, Privigen may be diluted with 5% glucose solution to a final concentration of 50 mg/ml (5%)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 220,
            "data": {
                "is_heading": 0,
                "text": "B) Vigam 50 mg/ml (5%) solution:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 221,
            "data": {
                "is_heading": 0,
                "text": "Vigam is administered intravenously at an initial rate of 0.01 - 0.02 ml/kg/minute for 30 minutes. If well tolerated, the rate of administration may be gradually increased to 0.04 mL/kg/minute up to a maximum of 3 ml/minute, for the remainder of the infusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 222,
            "data": {
                "is_heading": 0,
                "text": "c) Intratect 50 mg/ml (5%) solution:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 223,
            "data": {
                "is_heading": 0,
                "text": "Intratectshould be infused intravenously at an initial rate of not more than 1.4 ml/kg/h for 30 minutes. If well tolerated, the rate of administration may gradually be increased to a maximum of 1.9 ml/kg/h for the remainder of the infusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 224,
            "data": {
                "is_heading": 1,
                "text": "Appendix A"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 225,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 226,
            "data": {
                "is_heading": 1,
                "text": "Appendix B"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 227,
            "data": {
                "is_heading": 1,
                "text": "Management Plan for Suspected Childhood ITP"
            }
        },
        {
            "type": "image",
            "sequence_num": 228,
            "data": {
                "url": "14028 Children  YP with Acute Immune Thrombocytopenic Purpura 2.0.007.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 229,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 230,
            "data": {
                "is_heading": 1,
                "text": "What is Childhood ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 231,
            "data": {
                "is_heading": 1,
                "text": "The ITP Support Association parent leaflet"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 232,
            "data": {
                "is_heading": 1,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 233,
            "data": {
                "is_heading": 0,
                "text": "This leaflet explains about immune thrombocytopenic purpura (ITP), which is a blood disorder affecting the platelets. It also explains what to expect when your child is diagnosed with the condition."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 234,
            "data": {
                "is_heading": 1,
                "text": "What are platelets?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 235,
            "data": {
                "is_heading": 0,
                "text": "Platelets are one of the three types of blood cell, along with red and white blood cells. Platelets are small and sticky and their job is to prevent bruising and stop bleeding after an injury. Platelets, like red and white blood cells, are formed in the bone marrow. A rough idea of how many platelets are circulating in the bloodstream (platelet count) can be made using a sample of blood. The normal platelet count is between is 150 to 400 x 109/l. In most cases of ITP the platelet count is less than 20 x 109/l. A low platelet count is called \u2018thrombocytopenia'."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 236,
            "data": {
                "is_heading": 1,
                "text": "What is immune thrombocytopenic purpura?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 237,
            "data": {
                "is_heading": 0,
                "text": "Immune thrombocytopenic purpura is a medical term for a condition in which there is bruising (purpura) because there are fewer platelets in the blood than usual (thrombocytopenic) and is usually caused by something going wrong with the immune system (the body's defence against infection) or an allergic reaction of some kind."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 238,
            "data": {
                "is_heading": 0,
                "text": "Chronic ITP is the term for ITP that has not gone away on its own after 6 months. Only 1 in 4 children with ITP will develop chronic ITP. The majority of children with \"chronic\" ITP will still have some recovery of the platelet count at a later date and the majority of younger children will still completely recover after a few years even if the ITP is still present at 6 months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 239,
            "data": {
                "is_heading": 1,
                "text": "How common is ITP and who does it affect?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 240,
            "data": {
                "is_heading": 0,
                "text": "About four in every 100,000 children develop ITP each year. There seem to be two groups who develop ITP: young children and young adults. It is more common in girls than boys."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 241,
            "data": {
                "is_heading": 1,
                "text": "What are the symptoms of ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 242,
            "data": {
                "is_heading": 0,
                "text": "Most children with a platelet count of under 20 x 109/l will have petechiae (pinprick blood spots under the skin) and limited bruising. Bruising most commonly follows minor knocks (\"easy bruising\") but may also occur spontaneously without trauma. Apart from the bruising/ bleeding the children are otherwise well. Common sites of spontaneous bleeding are the gums and nose. Girls may be troubled with heavy periods."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 243,
            "data": {
                "is_heading": 0,
                "text": "Less common and potentially serious are spontaneous bleeds occurring from the gut or brain. Data from international studies suggests that the risk of serious bleeds is about 3 in 100 children and the risk of brain bleeds is about 1 in 300 children. These bleeds most often occurred in the first week of ITP and were often caused by a rare pre-existing abnormality of the blood vessels in the head. The risk of serious bleeding is much lower when the platelet count recovers to over 20 x 109/l."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 244,
            "data": {
                "is_heading": 1,
                "text": "What causes ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 245,
            "data": {
                "is_heading": 1,
                "text": "Appendix C"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 246,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 247,
            "data": {
                "is_heading": 1,
                "text": "ITP commonly results due to the immune system mistaking platelets as being foreign and attacking the platelets. In many cases this may follow a viral infection or vaccination during which time the immune system attacks the virus but the immune system then goes on to think that the platelets are viral material and starts to attack the platelets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 248,
            "data": {
                "is_heading": 1,
                "text": "How is ITP diagnosed?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 249,
            "data": {
                "is_heading": 0,
                "text": "ITP is usually diagnosed using a blood test called a \u2018full blood count'. When a sample of your child's blood is examined under a microscope, a haematologist can examine each blood cell type closely. This is to rule out other conditions that may cause similar symptoms to ITP. If the platelets, red blood cells and white blood cells all look normal, this rules out leukaemia. If the low platelet count improves quickly and no treatment is needed, your child will not need any further tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 250,
            "data": {
                "is_heading": 0,
                "text": "If the platelet count is not showing signs of recovery by 3 to 6 months then a small sample of bone marrow will need to be taken and examined under the microscope. Additional blood tests may be taken at this time to exclude rare clotting or immune diseases that can mimic ITP. If the bone marrow"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 251,
            "data": {
                "is_heading": 0,
                "text": "looks normal, with the usual or higher number of platelet parent cells (megakaryocytes) and other blood tests are normal then the doctor will diagnose chronic ITP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 252,
            "data": {
                "is_heading": 1,
                "text": "What is the outlook for children with ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 253,
            "data": {
                "is_heading": 0,
                "text": "Many children, particularly younger ones, suddenly improve within six weeks, whether or not treatment has been given. Three out of four children will have improved by 6 months after the start of ITP. Even those who fail to recover completely will reach a platelet count over 20 x 109/l and have fewer bleeding problems. After six months about 25% of children will fully recover over the following year and over half will recover over several years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 254,
            "data": {
                "is_heading": 0,
                "text": "When ITP recovers about one in 20 children will have a further occurrence in the future."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 255,
            "data": {
                "is_heading": 1,
                "text": "How is ITP treated?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 256,
            "data": {
                "is_heading": 0,
                "text": "Most children do not need any treatment unless they have severe bleeding, and most children improve whether or not treatment is given. The type of treatment recommended depends on your child's symptoms rather than their platelet count. All the various forms of treatment aim to temporarily improve the platelet count and do not cure the condition itself. When treatments are considered, you will have the chance to discuss the risks and benefits of these, as opposed to no treatment, with the doctor. The options for treating ITP include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 257,
            "data": {
                "is_heading": 1,
                "text": "1) No treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 258,
            "data": {
                "is_heading": 0,
                "text": "The majority of children with ITP have a low platelet count but do not have dangerous bleeding. If severe bleeding is not present at the time of diagnosis then it is very rare for dangerous bleeding to develop later. Without treatment most children will have a platelet count > 20 x109/l within 5 days and a normal platelet count by six months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 259,
            "data": {
                "is_heading": 1,
                "text": "2) Tranexamic acid"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 260,
            "data": {
                "is_heading": 0,
                "text": "Tranexamic acid does not increase the platelet count but does help the blood to produce clots. It is particularly useful for gum bleeds, nose bleeds or heavy periods and helps the blood to form clots without altering the platelet count. It is best taken as a liquid (\"swish and swallow\") three times per day. It most not be used if there is any blood in the urine."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 261,
            "data": {
                "is_heading": 1,
                "text": "3) Steroid treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 262,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 263,
            "data": {
                "is_heading": 0,
                "text": "Steroids are sometimes given to children with ITP on a short-term basis in an attempt to increase their platelet count. However, when the steroid dose is reduced, the platelet count will drop again after a few days. Steroids should only be given for a short period of between 4 to 7 days. Side effects such as weight gain and mood changes are common. Longer courses of steroids may dampen the immune system, weaken bones, cause diabetes or obesity and stunt growth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 264,
            "data": {
                "is_heading": 1,
                "text": "3) Intravenous immunoglobulin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 265,
            "data": {
                "is_heading": 0,
                "text": "Immunoglobulins are antibodies which can reduce platelet destruction. They are a blood product produced from many donors and have a theoretical but very low risk of transmitting blood-borne infections. One course of treatment with immunoglobulin takes two to five days as an in-patient in the hospital and the benefit will usually last about a month. Side effects such as fever and headaches are common."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 266,
            "data": {
                "is_heading": 1,
                "text": "4) Anti \u2013 D (WinRho)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 267,
            "data": {
                "is_heading": 0,
                "text": "WinRho can be used in Rhesus positive children (about 85% of children). WinRho is similar to immunoglobulin in producing antibodies which the immune system targets rather than the platelets. Anti-D is also a blood product but produced from a small number of donors. A small drop in the haemoglobin is common, rarely (1 in 40000 recipients) a severe and dangerous drop in the haemoglobin is seen. Anti-D can be given as a day case over about ten minutes and the benefit may last for several weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 268,
            "data": {
                "is_heading": 1,
                "text": "5) Splenectomy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 269,
            "data": {
                "is_heading": 0,
                "text": "In ITP the majority of platelets are destroyed in the spleen. Removing the spleen (splenectomy) is often effective in preventing early destruction of the platelets and allows the count to rise. In children however this is rarely necessary unless the ITP persists and the child has recurrent severe bleeds. Splenectomy is a major surgical procedure and carries a long term risk of severe infection."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 270,
            "data": {
                "is_heading": 1,
                "text": "What about school, sport and holidays?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 271,
            "data": {
                "is_heading": 0,
                "text": "Most severe bleeds tend to occur in the first week and in children with a platelet count under 20 x109/l. In those children with a count over 20 x109/l they can return to school immediately after the head teacher has been informed about the ITP. In children with a lower platelet count school can resume after the first week and when the school have been informed. For primary school aged children it may be best if they take breaks inside if these can not be supervised. The ITP Support Association produces a document for schools, clubs and playgroups."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 272,
            "data": {
                "is_heading": 0,
                "text": "If your child is on steroids and has not had chicken pox then school will need to inform you if anyone in your child's class/nursery comes down with chicken pox."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 273,
            "data": {
                "is_heading": 0,
                "prefix": 50.0,
                "text": "At home it is best to take sensible precautions which all children should follow such only cycling with a helmet and if swimming no diving into the shallow end! It is sensible to avoid sports where there is a risk of head injury whilst the platelet count is below  x109/l. Make sure any sports teachers are aware. With a platelet count between 50 and 100 x109/l there will still be more bruising so encourage the use of shin pads etc. For further details discuss with your consultant."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 274,
            "data": {
                "is_heading": 0,
                "text": "It is best not to take any holidays abroad in the first three months of ITP as it may be difficult to get insurance. After this time most cases of ITP will have resolved. If the ITP does persist you will need to discuss further with your doctor and you will need specialist medical insurance. A list of recommended insurance companies can be obtained from ITP Support Association (details below)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 275,
            "data": {
                "is_heading": 1,
                "text": "What else can I do?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 276,
            "data": {
                "is_heading": 0,
                "text": "Your child should also avoid drugs like aspirin, ibuprofen or herbal medication which can increase the risk of bruising and bleeding. Finally, you should make sure that doctors and dentists know that your child has a low platelet count if they are due to have an operation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 277,
            "data": {
                "is_heading": 1,
                "text": "When to seek help?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 278,
            "data": {
                "is_heading": 0,
                "text": "When your child is sent home you will be given a clinic appointment for review at the hospital and an emergency number (usually the phone number to the children's ward). You should contact the hospital in the following circumstances:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 279,
            "data": {
                "is_heading": 0,
                "text": "A prolonged (over 30 minutes) nosebleed which will not stop despite pinching the nose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 280,
            "data": {
                "is_heading": 0,
                "text": "Prolonged gum bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 281,
            "data": {
                "is_heading": 0,
                "text": "Blood in the poo or urine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 282,
            "data": {
                "is_heading": 0,
                "text": "Following a heavy blow to the head, particularly if the child is stunned or sickly"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 283,
            "data": {
                "is_heading": 0,
                "text": "Persistent or severe headache"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 284,
            "data": {
                "is_heading": 0,
                "text": "Vomiting or drowsiness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 285,
            "data": {
                "is_heading": 0,
                "text": "Children on steroids are at a greater risk of a severe form of chickenpox. If your child has not had chicken pox then contact the hospital If your child is in direct contact with someone who has chicken pox or who develops chickenpox within 7 days of being with your child."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 286,
            "data": {
                "is_heading": 0,
                "text": "www.itpsupport.org.uk"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 287,
            "data": {
                "is_heading": 1,
                "text": "Appendix D ITP in Children"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 288,
            "data": {
                "is_heading": 1,
                "text": "What is immune thrombocytopenic purpura?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 289,
            "data": {
                "is_heading": 0,
                "text": "Immune thrombocytopenic purpura is a medical term for a condition in which there is bruising (purpura) because there are fewer platelets in the blood than usual (thrombocytopenic) and is usually caused by something going wrong with the immune system (the body's defence against infection) or an allergic reaction of some kind."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 290,
            "data": {
                "is_heading": 0,
                "text": "Chronic ITP is the term for ITP that has not gone away on its own after 6 months. Only 1 in 4 children with ITP will develop chronic ITP. The majority of children with \"chronic\" ITP will still have some recovery of the platelet count at a later date and the majority of younger children will still completely recover after a few years even if the ITP is still present at 6 months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 291,
            "data": {
                "is_heading": 1,
                "text": "How common is ITP and who does it affect?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 292,
            "data": {
                "is_heading": 0,
                "text": "About four in every 100,000 children develop ITP each year. There seem to be two groups who develop ITP: young children and young adults. It is more common in girls than boys."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 293,
            "data": {
                "is_heading": 1,
                "text": "What are the symptoms of ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 294,
            "data": {
                "is_heading": 0,
                "text": "Most children with a platelet count of under 20 will have petechiae (pinprick blood spots under the skin) and limited bruising. Bruising most commonly follows minor knocks (\"easy bruising\") but may also occur spontaneously without trauma. Apart from the bruising/ bleeding the children are otherwise well. Common sites of spontaneous bleeding are the gums and nose. Girls may be troubled with heavy periods."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 295,
            "data": {
                "is_heading": 0,
                "text": "Less common and potentially serious are spontaneous bleeds occurring from the gut or brain. Data from international studies suggests that the risk of serious bleeds is about 3 in 100 children and the risk of brain bleeds is about 1 in 300 children. These bleeds most often occurred in the first week of ITP and were often caused by a rare pre-existing abnormality of the blood vessels in the head. The risk of serious bleeding is much lower when the platelet count recovers to over 20."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 296,
            "data": {
                "is_heading": 1,
                "text": "What causes ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 297,
            "data": {
                "is_heading": 1,
                "text": "ITP commonly results due to the immune system mistaking platelets as being foreign and attacking the platelets. In many cases this may follow a viral infection or vaccination during which time the immune system attacks the virus but the immune system then goes on to think that the platelets are viral material and starts to attack the platelets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 298,
            "data": {
                "is_heading": 1,
                "text": "How is ITP diagnosed?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 299,
            "data": {
                "is_heading": 0,
                "text": "ITP is usually diagnosed using a blood test called a \u2018full blood count'. When a sample of your child's blood is examined under a microscope, a haematologist can examine each blood cell type closely. This is to rule out other conditions that may cause similar symptoms to ITP. If the platelets, red blood cells and white blood cells all look normal, this rules out leukaemia. If the low platelet count improves quickly and no treatment is needed, your child will not need any further tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 300,
            "data": {
                "is_heading": 0,
                "text": "If the platelet count is not showing signs of recovery by 3 to 6 months then a small sample of bone marrow will need to be taken and examined under the microscope. Additional blood tests may be taken at this time to exclude rare clotting or immune diseases that can mimic ITP. If the bone marrow looks normal, with the usual or higher number of platelet parent cells (megakaryocytes) and other blood tests are normal then the doctor will diagnose chronic ITP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 301,
            "data": {
                "is_heading": 1,
                "text": "What is the outlook for children with ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 302,
            "data": {
                "is_heading": 0,
                "text": "Many children, particularly younger ones, suddenly improve within six weeks, whether or not treatment has been given. Three out of four children will have improved by 6 months after the start of ITP. Even those who fail to recover completely will reach a platelet count over 20 and have fewer bleeding problems. After six months about 25% of children will fully recover over the following year and over half will recover over several years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 303,
            "data": {
                "is_heading": 0,
                "text": "When ITP recovers about one in 20 children will have a further occurrence in the future."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 304,
            "data": {
                "is_heading": 1,
                "text": "How is ITP treated?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 305,
            "data": {
                "is_heading": 0,
                "text": "Most children do not need any treatment unless they have severe bleeding, and most children improve whether or not treatment is given. The type of treatment recommended depends on your child's symptoms rather than their platelet count. All the various forms of treatment aim to temporarily improve the platelet count and do not cure the condition itself. When treatments are considered, you will have the chance to discuss the risks and benefits of these, as opposed to no treatment, with the doctor. The options for treating ITP include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 306,
            "data": {
                "is_heading": 0,
                "text": "1) No treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 307,
            "data": {
                "is_heading": 0,
                "text": "The majority of children with ITP have a low platelet count but do not have dangerous bleeding. If severe bleeding is not present at the time of diagnosis then it is very rare for dangerous bleeding to develop later. Without treatment most children will have a platelet count over 20 within 5 days and a normal platelet count by six months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 308,
            "data": {
                "is_heading": 0,
                "text": "2) Tranexamic acid"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 309,
            "data": {
                "is_heading": 0,
                "text": "Tranexamic acid does not increase the platelet count but does help the blood to produce clots. It is particularly useful for gum bleeds, nose bleeds or heavy periods and helps the blood to form clots without altering the platelet count. It is best taken as a liquid (\"swish and swallow\") three times per day. It most not be used if there is any blood in the urine."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 310,
            "data": {
                "is_heading": 0,
                "text": "3) Steroid treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 311,
            "data": {
                "is_heading": 0,
                "text": "Steroids are sometimes given to children with ITP on a short-term basis in an attempt to increase their platelet count. However, when the steroid dose is reduced, the platelet count will drop again after a few days. Steroids should only be given for a short period of between 4 to 7 days. Side effects such as weight gain and mood changes are common. Longer courses of steroids may dampen the immune system, weaken bones, cause diabetes or obesity and stunt growth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 312,
            "data": {
                "is_heading": 0,
                "text": "3) Intravenous immunoglobulin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 313,
            "data": {
                "is_heading": 0,
                "text": "Immunoglobulins are antibodies which can reduce platelet destruction. They are a blood product produced from many donors and have a theoretical but very low risk of transmitting blood-borne infections. One course of treatment with immunoglobulin takes two to five days as an in-patient in the hospital and the benefit will usually last about a month. Side effects such as fever and headaches are common."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 314,
            "data": {
                "is_heading": 0,
                "text": "4) Anti \u2013 D (WinRho)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 315,
            "data": {
                "is_heading": 0,
                "text": "WinRho can be used in Rhesus positive children (about 85% of children). WinRho is similar to immunoglobulin in producing antibodies which the immune system targets rather than the platelets. Anti-D is also a blood product but produced from a small number of donors. A small drop in the haemoglobin is common, rarely (1 in 40000 recipients) a severe and dangerous drop in the haemoglobin is seen. Anti-D can be given as a day case over about ten minutes and the benefit may last for several weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 316,
            "data": {
                "is_heading": 0,
                "text": "5) Splenectomy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 317,
            "data": {
                "is_heading": 0,
                "text": "In ITP the majority of platelets are destroyed in the spleen. Removing the spleen (splenectomy) is often effective in preventing early destruction of the platelets and allows the count to rise. In children however this is rarely necessary unless the ITP persists and the child has recurrent severe bleeds. Splenectomy is a major surgical procedure and carries a long term risk of severe infection."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 318,
            "data": {
                "is_heading": 1,
                "text": "What else can I do?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 319,
            "data": {
                "is_heading": 0,
                "text": "Your child should also avoid drugs like aspirin, ibuprofen (calprofen) or herbal medication which can increase the risk of bruising and bleeding. Finally, you should make sure that doctors and dentists know that your child has a low platelet count if they are due to have an operation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 320,
            "data": {
                "is_heading": 1,
                "text": "When to seek help?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 321,
            "data": {
                "is_heading": 0,
                "text": "When your child is sent home you will be given a clinic appointment for review at the hospital and an emergency number (usually the phone number to the children's ward). You should contact the hospital in the following circumstances:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 322,
            "data": {
                "is_heading": 0,
                "text": "A prolonged (over 30 minutes) nosebleed which will not stop despite pinching the nose Prolonged gum bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 323,
            "data": {
                "is_heading": 0,
                "text": "Blood in the poo or urine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 324,
            "data": {
                "is_heading": 0,
                "text": "Following a heavy blow to the head, particularly if the child is stunned or sickly Persistent or severe headache"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 325,
            "data": {
                "is_heading": 0,
                "text": "Vomiting or drowsiness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 326,
            "data": {
                "is_heading": 0,
                "text": "Children on steroids are at a greater risk of a severe form of chickenpox. If your child has not had chicken pox then contact the hospital If your child is in direct contact with someone who has chicken pox or who develops chickenpox within 7 days of being with your child."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 327,
            "data": {
                "is_heading": 1,
                "text": "Is there a UK registry?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 328,
            "data": {
                "is_heading": 0,
                "text": "To maintain accurate numbers of cases of childhood ITP and investigate possible markers for risk of severe bleeding a UK registry has been established (www.uk-itp.org) Families may be routinely asked to consent for anonymous data to be stored on the registry."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 329,
            "data": {
                "is_heading": 1,
                "text": "Further reading: The ITP Support Association produces the following booklets available free of charge to members."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 330,
            "data": {
                "is_heading": 0,
                "text": "An illustrated booklet to help young children understand ITP. In 2 versions, James tells his story and Jessica tells her story."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 331,
            "data": {
                "is_heading": 0,
                "text": "A booklet for parents, 'What did you call it?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 332,
            "data": {
                "is_heading": 0,
                "text": "A \"School Guidelines 'leaflet for schools and playgroups"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 333,
            "data": {
                "is_heading": 0,
                "text": "A 'Pupil's Factsheet' for schools"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 334,
            "data": {
                "is_heading": 0,
                "text": "https://www.itpsupport.org.uk/index.php/en/information/itp-in-children"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 335,
            "data": {
                "is_heading": 1,
                "text": "Appendix E"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 336,
            "data": {
                "is_heading": 1,
                "text": "ITP in Teenagers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 337,
            "data": {
                "is_heading": 1,
                "text": "What is immune thrombocytopenia?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 338,
            "data": {
                "is_heading": 0,
                "text": "Immune thrombocytopenia is a medical term for a condition in which there is bruising (purpura) because there are fewer platelets in the blood than usual (thrombocytopenia) and is usually caused by something going wrong with the body's defence against infection (immune system) or an allergic reaction of some kind."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 339,
            "data": {
                "is_heading": 1,
                "text": "How common is ITP and who does it affect?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 340,
            "data": {
                "is_heading": 0,
                "text": "About four in every 100,000 children develop ITP each year. In teenagers ITP is more common in girls than boys."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 341,
            "data": {
                "is_heading": 0,
                "text": "Chronic ITP is the term for ITP that has not gone away on its own after 12 months. Only 1 in 5 teenagers and adolescents with ITP will develop chronic ITP with teenage girls at highest risk. The majority of teenagers and adolescents with ITP will still have an improvement of the platelet count even if the ITP persists and the majority of teenagers and adolescents will still completely recover after a few years even if the ITP is still present at 12 months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 342,
            "data": {
                "is_heading": 1,
                "text": "What are the symptoms of ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 343,
            "data": {
                "is_heading": 0,
                "text": "Most teenagers and adolescents with a platelet count of under 20 will have pinprick blood spots under the skin (petechiae) and bruising. Bruising most commonly follows minor knocks (\"easy bruising\") but may also occur spontaneously without trauma. Apart from the bruising/ bleeding most adolescents are otherwise well. Common sites of spontaneous bleeding are the gums and nose. Girls may be troubled with heavy periods."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 344,
            "data": {
                "is_heading": 0,
                "text": "Tiredness and depression or other mood changes are commonly reported by people with ITP. This may be due to a change in chemicals which are carried by platelets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 345,
            "data": {
                "is_heading": 0,
                "text": "Less common but potentially serious are spontaneous bleeds occurring from the gut or brain. Data from worldwide studies suggests that the risk of serious bleeds is about 3 in 100 and the risk of brain bleeds is about 1 in 300. The risk of serious bleeding is much lower when the platelet count recovers to over 20 x 109/Litre."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 346,
            "data": {
                "is_heading": 1,
                "text": "What causes ITP?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 347,
            "data": {
                "is_heading": 0,
                "text": "ITP commonly results from the immune system mistaking platelets as being foreign and attacking them. In many cases this may follow a viral infection or vaccination during which time the immune system attacks the virus but the immune system then goes on to think that the platelets are part of the virus and starts to attack the platelets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 348,
            "data": {
                "is_heading": 1,
                "text": "How is ITP diagnosed?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 349,
            "data": {
                "is_heading": 0,
                "text": "ITP is usually diagnosed using a blood test called a \u2018full blood count'. When a sample of your blood is looked at under a microscope, a blood doctor can examine each blood cell type closely. This is to rule out other conditions that may cause similar symptoms to ITP. If the platelets, red blood cells and white blood cells all look normal, this rules out blood cancer (leukaemia). If the low platelet count improves quickly and no treatment is needed, you will not need any further tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 350,
            "data": {
                "is_heading": 0,
                "text": "If the platelet count is not showing signs of recovery by 3 to 6 months then a small sample of bone marrow will need to be taken and looked at under the microscope. Additional blood tests may be taken at this time to rule out rare problems with making blood clots and rare problems of the immune system that can look like ITP. If the bone marrow looks normal, with the usual or higher number of cells that make platelets (megakaryocytes), and other blood tests are normal, then the doctor will diagnose persistent ITP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 351,
            "data": {
                "is_heading": 1,
                "text": "How is ITP treated?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 352,
            "data": {
                "is_heading": 0,
                "text": "Most teenagers and adolescents do not need any treatment unless they have severe bleeding, and most teenagers and adolescents improve whether or not treatment is given. The type of treatment recommended depends on your symptoms rather than your platelet count. Most treatments aim to temporarily improve the platelet count and do not cure the condition itself. When treatments are considered, you will have the chance to discuss the risks and benefits of these, as opposed to no treatment, with the doctor. The options for treating ITP include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 353,
            "data": {
                "is_heading": 0,
                "text": "1) No treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 354,
            "data": {
                "is_heading": 0,
                "text": "The majority of teenagers and adolescents with ITP have a low platelet count but do not have dangerous bleeding. Without treatment most teenagers and adolescents will have a platelet count over 20 within 5 days and a normal platelet count by six months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 355,
            "data": {
                "is_heading": 0,
                "text": "2) Tranexamic acid"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 356,
            "data": {
                "is_heading": 0,
                "text": "Tranexamic acid does not increase the platelet count but does help the blood to produce clots. It is particularly useful for gum bleeds, nose bleeds or heavy periods and helps the blood to form clots without altering the platelet count. It is best taken as a liquid (\"swish and swallow\") three times per day. It must not be used if there is any blood in the urine."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 357,
            "data": {
                "is_heading": 0,
                "text": "3) Hormonal treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 358,
            "data": {
                "is_heading": 0,
                "text": "Norethisterone is a drug used to stop girls' periods. This is done if their periods are extremely heavy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 359,
            "data": {
                "is_heading": 0,
                "text": "Oral contraceptive pill \u2013 teenage girls with ITP can be put on the oral contraceptive pill to try and reduce heavy periods."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 360,
            "data": {
                "is_heading": 0,
                "text": "4) Steroid treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 361,
            "data": {
                "is_heading": 0,
                "text": "Steroids are sometimes given to teenagers and adolescents with ITP on a short-term basis in an attempt to increase their platelet count. However, when the steroid dose is reduced, the platelet count will drop again after a few days. Steroids should only be given for a short period of between 4 to 7 days."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 362,
            "data": {
                "is_heading": 0,
                "text": "Side effects such as weight gain and mood changes are common. Some teenagers and adolescents become very worried about their mood changes when they're on steroids, so it is important to know that this is a perfectly normal side effect of the drug, as is increased appetite and disturbed sleep patterns."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 363,
            "data": {
                "is_heading": 0,
                "text": "Steroids can also affect your skin; you may notice that you get more spots while you are on the tablets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 364,
            "data": {
                "is_heading": 0,
                "text": "Longer courses of steroids are not recommended as this may dampen the immune system, weaken bones, cause diabetes or obesity and stunt growth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 365,
            "data": {
                "is_heading": 0,
                "text": "5) Intravenous immunoglobulin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 366,
            "data": {
                "is_heading": 0,
                "text": "Immunoglobulins are antibodies which can reduce platelet destruction. They are a blood product produced from many donors and have a theoretical but very low risk of transmitting blood-borne infections. One course of treatment with immunoglobulin takes a full day as an in-patient in the hospital and the benefit will usually last about a month. Side effects such as fever and headaches are common."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 367,
            "data": {
                "is_heading": 0,
                "text": "6) \u2018Curative' treatments"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 368,
            "data": {
                "is_heading": 0,
                "text": "Splenectomy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 369,
            "data": {
                "is_heading": 0,
                "text": "In ITP the majority of platelets are destroyed in the spleen. Removing the spleen (splenectomy) is often effective in preventing early destruction of the platelets and allows the count to rise. In teenagers and adolescents however this is rarely necessary unless the ITP persists and the child has recurrent severe bleeds. It is successful in about 3-4 out of 5 people. Splenectomy is a major surgical procedure and carries a long term risk of severe infection and blood clots. It is rarely performed as the risks of splenectomy usually outweigh the potential benefits. Alternative treatments such as rituximab or the newer TPO-mimetics are usually tried prior to considering splenectomy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 370,
            "data": {
                "is_heading": 0,
                "text": "Rituximab"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 371,
            "data": {
                "is_heading": 0,
                "text": "Rituximab kills the immune cells that clear the platelets out of the blood. By removing the cells that get rid of the platelets, the platelet count will increase. It is successful initially in about 2 in 3 people and can be curative in about one third. Side effects are common."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 372,
            "data": {
                "is_heading": 0,
                "text": "Eltrombopag and Nplate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 373,
            "data": {
                "is_heading": 0,
                "text": "These TPO-mimetic newer drugs increase the number of platelets that are made in the bone marrow without suppressing the immune system. They are currently not widely available for children or teenagers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 374,
            "data": {
                "is_heading": 1,
                "text": "What about school, sport and holidays?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 375,
            "data": {
                "is_heading": 0,
                "text": "Most severe bleeds tend to occur in the first week it develops and in teenagers and adolescents with a platelet count under 20. In those teenagers and adolescents with a count over 20 they can return to school/college/university immediately after the head teacher/tutor has been informed about the ITP. In teenagers and adolescents with a lower platelet count school can resume after the first week and when the school has been informed. The ITP Support Association produces a leaflet for schools/colleges/universities and clubs (available free of charge to members)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 376,
            "data": {
                "is_heading": 0,
                "text": "If you are on steroids and haven't had chicken pox then school will need to inform you if anyone in your class goes down with chicken pox."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 377,
            "data": {
                "is_heading": 0,
                "text": "As a general rule contact sports where there is a risk of head injury should only be undertaken with care with active ITP. When the platelet count is over 50 the only sports to avoid would be rugby, boxing and wrestling where serious injuries can occur. Below this level it is possible to undertake supervised training but taking precautions to wear the appropriate protective gear. These are only recommendations, and you should discuss with your doctor what you can and cannot do as everyone is different."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 378,
            "data": {
                "is_heading": 0,
                "text": "Common sense is important. You should take the proper precautions that each sport requires, for example you must wear a helmet if you go cycling and you should not run around the sides of a swimming pool, but everyone should be doing this anyway. Because you will bruise more easily than most people, it is a good idea if you wear knee and elbow pads during certain sports."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 379,
            "data": {
                "is_heading": 0,
                "text": "At school, you need to make sure your teachers are aware of your condition, and it is best if your parents do this with you."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 380,
            "data": {
                "is_heading": 0,
                "text": "It is best not to take any holidays abroad in the first three months of ITP as it may be difficult to get insurance. After this time most cases of ITP will have resolved. If the ITP does persist you will need to discuss further with your doctor and you may need specialist medical insurance. A list of recommended insurance companies is given in the ITP Support Association's Holiday Guide (available free of charge to members)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 381,
            "data": {
                "is_heading": 1,
                "text": "What else can I do?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 382,
            "data": {
                "is_heading": 0,
                "text": "You should also avoid drugs like aspirin, ibuprofen or herbal medication which can increase the risk of bruising and bleeding. Finally, you should make sure that doctors and dentists and any other medical practitioner you see know that you have a low platelet count."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 383,
            "data": {
                "is_heading": 1,
                "text": "When to seek help?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 384,
            "data": {
                "is_heading": 0,
                "text": "When you're sent home you will be given a clinic appointment for review at the hospital and an emergency number (usually the phone number to the hospital ward). You should tell your mum, dad or guardian if the following ever happen so they can contact the hospital:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 385,
            "data": {
                "is_heading": 0,
                "text": "A nosebleed which will not stop after 30 minutes despite pinching the nose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 386,
            "data": {
                "is_heading": 0,
                "text": "Prolonged gum bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 387,
            "data": {
                "is_heading": 0,
                "text": "Blood in the poo or urine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 388,
            "data": {
                "is_heading": 0,
                "text": "Following a heavy blow to the head, particularly if you are stunned or sickly"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 389,
            "data": {
                "is_heading": 0,
                "text": "Persistent or severe headache"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 390,
            "data": {
                "is_heading": 0,
                "text": "Vomiting or drowsiness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 391,
            "data": {
                "is_heading": 0,
                "text": "If you haven't had chicken pox and someone you meet or at school has the virus"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 392,
            "data": {
                "is_heading": 1,
                "text": "Is there a UK registry?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 393,
            "data": {
                "is_heading": 0,
                "text": "To maintain accurate numbers of cases of childhood ITP and investigate possible markers for risk of severe bleeding a UK registry has been established (www.uk-itp.org) Families may be routinely asked to consent for anonymous data to be stored on the registry."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 394,
            "data": {
                "is_heading": 1,
                "text": "Further reading"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 395,
            "data": {
                "is_heading": 0,
                "text": "The ITP Association has a booklet ITP \u2018n' Stuff specifically written for teenagers at school with ITP, available free of charge to members."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 396,
            "data": {
                "is_heading": 1,
                "text": "Appendix F"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 397,
            "data": {
                "is_heading": 1,
                "text": "Holiday Arrangements Summary"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 398,
            "data": {
                "is_heading": 1,
                "text": "Before you go:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 399,
            "data": {
                "is_heading": 0,
                "text": "Order the ITP Support Association's Holiday insurance and Travel Guide, which includes advice on insurance, flying, avoiding malaria, medicines and vaccinations, It also includes insurance companies recommended by our members."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 400,
            "data": {
                "is_heading": 0,
                "text": "If travelling to Europe get a European Health Insurance Card (EHIC) to entitle you to free or discounted healthcare in European countries."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 401,
            "data": {
                "is_heading": 0,
                "text": "Discuss any required vaccinations with your doctor well in advance, bearing in mind that they are not effective within 3 months of certain drugs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 402,
            "data": {
                "is_heading": 0,
                "text": "Order medication well in advance, ensuring you have enough to last the holiday. Inform your holiday insurance company about your ITP, or you may find you are not covered in the event of a claim (they may require a doctor's letter)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 403,
            "data": {
                "is_heading": 0,
                "text": "Try to find out what ITP is called in the country you are going to, in case of an emergency. You may be able to obtain this from the country's embassy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 404,
            "data": {
                "is_heading": 0,
                "text": "Find out what the equivalent of 999 is in the country you are visiting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 405,
            "data": {
                "is_heading": 0,
                "text": "Find out the locality of the doctor and hospital nearest to your accommodation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 406,
            "data": {
                "is_heading": 0,
                "text": "Make copies of all important documents, such as passports, and leave the copies with a friend of relative. You may need the copy if your originals get stolen."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 407,
            "data": {
                "is_heading": 1,
                "text": "If you take prescribed medicine, take a copy of your prescription and doctor's letter. Is Air Travel Safe?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 408,
            "data": {
                "is_heading": 1,
                "text": "Risk of bleeding?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 409,
            "data": {
                "is_heading": 0,
                "text": "The question of safety in air travel is one that needs to be considered individually. It is generally considered that there is little risk of bleeding if the platelet count is greater than 30 unless there is a history of bleeding problems at this level. If the platelet count is below 20 there may be a greater risk, although this is not necessarily related to flying but to the condition of the patient. There is no clear correlation between a low platelet count and bleeding manifestations, so it is better to discuss this individually with the doctor who knows your symptoms."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 410,
            "data": {
                "is_heading": 0,
                "text": "The ITP Support Association's medical advisors recommend that if the platelet count is around 30 or above and there are no bleeding problems, flying should present no additional risk. Some consultants express concern about their patients going on long-haul flights in pressurised cabins, but the Association's medical advisors in the UK and US agree that they know of no evidence that there is any increased risk of bleeding relating to air travel."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 411,
            "data": {
                "is_heading": 0,
                "text": "The national ITP guidelines approved by the British Committee for Standards in Haematology (published in the British Journal of Haematology back in 2003 contained the following statement: \u2018There is no evidence that air travel predisposes to bleeding in patients with ITP; there is no indication to treat the count prior to holidays other than to cover activities' . There has been no change of advice issued since. However, if you are prone to nose or mouth bleeds that require medical intervention you should consider whether you could cope with this mid-air."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 412,
            "data": {
                "is_heading": 1,
                "text": "Deep vein thrombosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 413,
            "data": {
                "is_heading": 0,
                "text": "The possibility of deep vein thrombosis on long-haul flights is now accepted as a recognised hazard for travellers. Extended periods sitting in a plane in cramped conditions (plus a spot of dehydration, booze and caffeine!) may encourage blood platelets to clump together in the veins to cause thrombosis. This is possible even with a low platelet count, and particularly with certain treatments."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 414,
            "data": {
                "is_heading": 0,
                "text": "Aspirin should always be avoided by thrombocytopenic patients, despite the advice to other passengers that it be taken when flying. Flexing toes, ankles and knees while seated, plus a periodic walk up and down the plane, will help to keep the blood moving during the flight. Drink plenty of water and avoid too much alcohol."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 415,
            "data": {
                "is_heading": 0,
                "text": "https://www.itpsupport.org.uk/index.php/en/information/holidays-and-flying"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 416,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        }
    ]
}